Tango Therapeutics, Inc.TNGXNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank83
5Y CAGR+0.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+0.4%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$1.66M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$1.63M-95.0%
2019$32.27M-